文献速递乳房整形与再造

继发性假体乳房再造感染失败后第三次乳房再造的结局

Outcomes of Third-Attempt Breast Reconstruction following Infection-Associated Failure of Secondary Implant-Based Reconstruction.
PubMed 文献 · Plast Reconstr Surg · 2022-11-19

该回顾性研究分析了2000至2019年间6093例初次假体乳房再造患者中,13例因继发性假体乳房再造感染失败后接受第三次乳房再造的结局。第三次再造总成功率高,假体组成功率为78%、并发症率23%,自体组织再造成功率为100%。作者认为第三次乳房再造是安全可行的选择。

要点

  • 6093例初次假体乳房再造中13例因继发感染失败后行第三次再造。
  • 第三次再造中9例(70%)采用假体,2例(15%)假体联合背阔肌皮瓣,2例(15%)腹部游离组织移植。
  • 假体组成功率78%、并发症率23%;自体组织再造成功率100%。

核心结论

  • 继发性假体乳房再造感染失败后行第三次乳房再造是安全可行的选择。
  • 尽管失败风险高于初次假体乳房再造,但继发感染后第三次尝试的成功率高达78%。

研究设计与样本

  • 回顾性综述,纳入2000至2019年接受乳房切除术后假体乳房再造的患者。
  • 分析继发性假体乳房再造因感染失败并最终接受第三次乳房再造患者的结局。
  • 6093例初次假体乳房再造患者中,13例接受第三次乳房再造。

主要发现

  • 13例第三次乳房再造患者中位年龄52岁(四分位距51至56岁),中位体重指数23 kg/m²(四分位距22至31 kg/m²),中位随访46个月(四分位距16至62个月)。
  • 第三次再造方式:9例(70%)假体乳房再造,2例(15%)假体联合带蒂背阔肌皮瓣,2例(15%)腹部游离组织移植。
  • 第三次再造时机:46%为即刻再造,54%为延迟再造。
  • 假体组成功率78%,并发症率23%。
  • 自体组织再造成功率100%,1例出现静脉淤血需重返手术室。

临床怎么用

  • 作者认为,继发性假体乳房再造感染失败后第三次乳房再造是安全可行的选择。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Implant-based reconstruction (IBR) is the most common method of breast reconstruction in the United States. Despite ongoing advancements, periprosthetic infection is a serious problem that often results in device explantation. The objective of this study was to evaluate the outcomes of third-attempt reconstruction in patients in whom secondary implant-based reconstruction failed because of infection. METHODS: The authors performed a retrospective review of patients who underwent mastectomy followed by IBR from 2000 to 2019. The outcomes of patients in whom secondary IBR failed because of infection and who ultimately underwent third-attempt breast reconstruction were analyzed. RESULTS: Of 6093 patients who underwent primary IBR, 13 patients had third-attempt breast reconstruction following infection-related explantation [median age, 52 years (interquartile range, 51 to 56 years); median body mass index, 23 kg/m 2 (interquartile range, 22 to 31 kg/m 2 ); median follow-up, 46 months (interquartile range, 16 to 62 months)]. Nine patients (70%) underwent IBR, two (15%) underwent IBR combined with pedicled latissimus dorsi flap, and two (15%) underwent abdominally based free tissue transfer. Third-attempt breast reconstruction was immediate in 46% of patients and delayed in 54%. The success rate was 78% in the IBR group, with a 23% complication rate. The success rate for autologous breast reconstruction was 100%, with one patient developing venous congestion necessitating return to the operating room. CONCLUSIONS: Third-attempt breast reconstruction following infection-associated failed secondary IBR is a safe and feasible option. Although the risk of failure is higher than that for primary implant-based reconstruction, a third attempt after secondary IBR infection had a surprisingly high 78% success rate. CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, III.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Hassan AM, Tran J, Asaad M, et al. Outcomes of Third-Attempt Breast Reconstruction following Infection-Associated Failure of Secondary Implant-Based Reconstruction. Plast Reconstr Surg. 2022. PMID: 36730488. doi:10.1097/PRS.0000000000009903

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。